Clinical trials: Periumbilical Subcutaneous Adipose Tissue Reduction
- Condition Periumbilical Subcutaneous Adipose Tissue Reduction
- Funder type Industry (pharma, biotech, devices)
Periumbilical Subcutaneous Adipose Tissue Reduction
Dose Ranging Study
Dose Ranging Study
- Trial name
- RESET (NCT01802723)
- Testing
- Drug: salmeterol xinafoate
- Where
- 22 sites in United States
- Volunteers
- 472 people, healthy volunteers welcome
- Sponsor
- Neothetics, Inc